UBS O'Connor’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-81,251
Closed -$3.21M 391
2025
Q2
$3.21M Sell
81,251
-9,528
-10% -$312K 0.09% 105
2025
Q1
$2.74M Buy
90,779
+30,199
+50% +$989K 0.07% 98
2024
Q4
$2.12M Buy
60,580
+23,623
+64% +$883K 0.05% 149
2024
Q3
$1.48M Sell
36,957
-5,638
-13% -$262K 0.04% 224
2024
Q2
$2.03M Buy
42,595
+183
+0.4% +$7.51K 0.06% 190
2024
Q1
$1.84M Buy
42,412
+13,788
+48% +$657K 0.05% 187
2023
Q4
$1.45M Sell
28,624
-33,435
-54% -$1.6M 0.05% 225
2023
Q3
$2.81M Sell
62,059
-10,000
-14% -$413K 0.05% 185
2023
Q2
$2.96M Sell
72,059
-35,430
-33% -$1.36M 0.06% 194
2023
Q1
$3.84M Buy
+107,489
New +$4.04M 0.09% 180
2022
Q4
Sell
-54,497
Closed -$2.41M 172
2022
Q3
$2.41M Sell
54,497
-7,000
-11% -$295K 0.03% 514
2022
Q2
$2.28M Buy
+61,497
New +$2.32M 0.02% 621
2020
Q1
Sell
-57,636
Closed -$3.48M 383
2019
Q4
$3.48M Buy
+57,636
New +$3.43M 0.1% 164

Other funds holding IONS